-transparent.png){kind=logo}
The gene for the bacterial enzyme carboxypeptidase G2 (CPG2) was expressed internally in mammalian cells. Mammalian-expressed CPG2 had kinetic properties indistinguishable from bacterially expressed CPG2. Human tumor cell lines A2780, SK-OV-3 (ovarian adenocarcinomas), LS174T, and WiDr (colon carcinomas) were engineered to express constitutively either CPG2 or bacterial beta-galactosidase. These cell lines were subjected to a gene-directed enzyme prodrug therapy regime, using the prodrug 4-[(2-chloroethyl)(2-mesyloxyethyl)amino]benzoyl-L-glutamic acid (CMDA). The lines which expressed CPG2 had enhanced sensitivity to CMDA. Comparing IC50S, WiDr-CPG2 and SK-OV-3-CPG2 were 11-16-fold more sensitive, whereas A2780-CPG2 and LS174T-CPG2 were approximately 95-fold more sensitive than the corresponding control lines. CPG2-expressing cells and control cells were mixed in differing proportions and then treated with prodrug. Total kill occurred when only approximately 12% of cells expressed CPG2 with the WiDr and SK-OV-3 lines and when only 4-5% of cells expressed CPG2 with the LS174T and A2780 lines, indicating a substantial bystander effect. These results establish this CPG2 enzyme/CMDA prodrug system as an effective combination for the gene-directed enzyme prodrug therapy approach.
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
November 2007,
Nature reviews. Cancer,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
June 2005,
Cancer research,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
March 1999,
Journal of medicinal chemistry,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
July 1995,
Anti-cancer drug design,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
January 1993,
Cell biophysics,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
January 2015,
The AAPS journal,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
August 2005,
Journal of medicinal chemistry,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
June 1997,
Expert opinion on investigational drugs,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
January 2002,
Acta biochimica Polonica,
R Marais, and
R A Spooner, and
Y Light, and
J Martin, and
C J Springer
June 2013,
Molecular cancer,
